PHDP5 Research for Alzheimer Disease

Introduction 

Currently, there is no cure for Alzheimer’s disease, a progressive neurodegenerative condition that affects millions of people worldwide. However, treatments are available to help manage its symptoms, such as memory loss, confusion, and difficulties with thinking and reasoning. While these therapies do not stop the disease, some have shown promise in slowing its progression, offering hope for improving the quality of life for those affected.

Alzheimer’s is characterized by the abnormal accumulation of proteins in the brain, such as beta-amyloid plaques and tau tangles, which interfere with the transmission of nerve impulses and disrupt normal brain function. These proteins build ups damage and ultimately kill brain cells, leading to the cognitive and functional decline associated with the disease.

In a groundbreaking study, researchers tested a synthetic peptide on mice genetically engineered to develop Alzheimer’s-like symptoms. The findings were promising, showing that the treatment significantly reduced the buildup of these harmful proteins in the brain. Even more compelling, the peptide therapy appeared to restore key cognitive functions, such as memory and learning, which are typically impaired in Alzheimer’s patients.

This study written about below highlights the potential of innovative therapeutic approaches to target the root causes of Alzheimer’s, rather than just addressing its symptoms. While further research, including human trials, is necessary to validate these findings, this development represents a significant step forward in the quest for more effective treatments and, ultimately, a cure for Alzheimer’s disease.

The problem

As global life expectancy continues to rise, dementia has become an increasingly pressing public health challenge. The prevalence of dementia is projected to grow significantly, with studies estimating that over 150 million people worldwide could be affected by 2050. This staggering statistic underscores the urgent need for effective prevention and treatment strategies.

Alzheimer’s disease, the most common form of dementia, is characterized by a variety of debilitating symptoms, including memory loss, cognitive decline, and personality changes. These symptoms are widely believed to result from the accumulation of two key proteins in the brain: beta-amyloid (Aβ) and tau. Beta-amyloid forms sticky plaques between neurons, while tau creates tangles within neurons, disrupting their structure and function. Together, these protein abnormalities lead to widespread neuronal damage, brain shrinkage, and the hallmark symptoms of Alzheimer’s.

Current treatments for Alzheimer’s primarily focus on alleviating symptoms, such as cognitive deficits and behavioral changes, rather than addressing the underlying causes of the disease. However, recent advancements have introduced disease-modifying therapies that aim to directly target these pathological proteins. For example, aducanumab and lecanemab, two monoclonal antibody treatments, have shown promise in reducing Aβ plaques in the brain. These therapies mark a significant step forward in targeting the disease at its root.

Despite these advancements, the use of monoclonal antibody treatments has sparked debate within the medical community. While they offer

What Are Peptides?

What Are Peptides?

Peptides and proteins are both made up of amino acids that are linked together (by peptide bonds, hence the name) in long chains called polymers. The only thing that separates peptides from proteins is how big they are. While there is no absolute cutoff, peptides are made up of fewer amino acids than proteins and hence are much smaller. In general, any amino acid chain that is longer than fifty residues in length is referred to as a protein. This is because after growing beyond 50 amino acids, peptides start to fold back on themselves creating shapes and bonds that are referred to as secondary structure. Peptides are almost always linear, with minimal secondary structure (lariat loops are sometimes observed), hence the size cut off.

So, peptides are smaller, simpler versions of proteins. But saying that does not do justice to the role these biochemicals play in everyday life. Research shows that peptides are primarily signaling molecules used to alter the ebb and flow of major biological systems. Peptides influence things like immune regulation, growth hormone release, extracellular matrix production, nerve cell growth and migration, and much more. Peptides are the keys to starting and stopping major biochemical cascades and, as such, are of the utmost importance to proper biological function.

It’s important to remember that we consume peptides on a daily basis. Eggs, milk, beans, meat, oats, and wheat all contain peptides, proteins, and various other biologically active molecules. In addition, many popular supplements, energy drinks, and health foods are enriched with peptides that help to improve body composition, boost energy, and aid digestion. Examples of common peptides found in everyday products include collagen and creatine.

Peptide Classes

Peptides are generally divided into groupings based on their function. For instance, there are antibacterial peptides, vaccine peptides, and anticancer peptides. Unfortunately, these peptide categories often overlap, which makes strict categorization difficult and confusing. For instance, brain peptides and immune peptides often overlap. The same is true of skin peptides and immune peptides as well as skin peptides and tendon peptides. Categorizing peptides by where they are located is an untenable approach because they are often found in various tissues.

Another way to categorize peptides that may be more useful is to consider their major actions. In that case, it would be useful to think about healing peptides, growth peptides, longevity peptides, fat-burning peptides, anti-inflammatory peptides, and so forth. While this approach is better than the above, it is still complicated by the fact that most peptides cross category boundaries. BPC-157, for instance, is a healing peptide and an anti-inflammatory peptide.

It is important not to get caught up in categories like “brain peptide” or “healing peptide” as they often don’t capture the entirety of a peptide’s biological activity. The better way to approach them is to look at the biochemical pathways

Peptide Guide

Peptides Guide | What to Know in 2024

Peptides have played an important role in medicine starting with the advent of insulin therapy in the 1920s. Since then, more than 60+ different peptides have been approved for used in the United States. Clearly peptides have been around in the research community for some time, but 2023 marks a major shift in which discussion of peptides has penetrated the mainstream. More than ever before, the public is aware of the benefits and potential of peptides in everything from reducing cancer risk to weight loss and sexual well-being. With increased public interest, increases in research funding are sure to come. As of 2018, there were more than 150 peptides in active development that had entered human clinical trials. That number has only increased since[1]. This peptides guide looks at trends in peptides research and lists a few of the most popular peptide classes that you should know about in 2023.

What Are Peptides?

Peptides are basically shorter versions of proteins, which is to say chains of amino acids connected into a specific sequence. They are a naturally occurring product that, thanks to the miracles of modern science, can be synthesized in laboratories and on an industrial scale. Peptides, it turns out, are critical to a lot of signaling cascades within the body. They regulate energy balance, feeding behavior, sleep, fatigue, sexual arousal, brain function, and even how quickly we heal. Peptides have been shown to play important roles in the body’s response to exercise and injury. They even determine how quickly we age.

Trends in Peptide Research

As the ability to synthesize synthetic peptides has grown over the decades since the 1920s, something interesting has happened. Science has slowly but surely moved away from simply trying to mimic the structure of natural peptides, a practice which necessarily limited development to shorter peptides, and has instead focused on developing novel peptides that act on receptors of interest even if they bear no resemblance to native peptides.

Trend in peptide length by decade:

Source: Science Direct

On average, the development time for a peptide is about 9.4 years and there are often setbacks along the way. Sometimes, peptides that are rejected as unsuitable for use get a second chance when they are altered, combined with other peptides, or applied in a new setting. As the catalog of therapeutic peptides has grown, so too has the research grown with it. For instance, the rate of discovery of peptide-addressable targets for which no peptide has yet been discovered or developed has helped to spur a frenzy of research activity. For instance, development of a melanocortin 4 receptor (MC4R) agonist could be critical in the fight against obesity and is of intense research focus. Scientists have identified the receptor, now they

NAD⁺ and Glutathione: Anti-Aging Research Benefits & Synergistic Potential

  Aging is inevitable, but emerging research suggests that its rate may be modulated by molecular interventions. In the rapidly advancing field of longevity science, two molecular factors—nicotinamide adenine dinucleotide (NAD⁺) and glutathione (GSH)—have gained prominence for their roles in healthy aging. NAD⁺ is a coenzyme central to metabolic energy production and DNA repair, while GSH is the predominant intracellular antioxidant. Both NAD⁺ and glutathione levels decline with age, a change that can compromise cellular function and resilience. This article examines the roles of NAD⁺ and glutathione in aging, their individual contributions to cellular homeostasis, and how enhancing their levels—individually or in combination—might promote a longer health span.

NAD⁺

            NAD⁺ (nicotinamide adenine dinucleotide) is a ubiquitous coenzyme present in every cell. It plays a pivotal role in cellular metabolism by facilitating the transfer of electrons in critical biochemical pathways, thereby driving the production of ATP. NAD⁺ continuously cycles between an oxidized form (NAD⁺) and a reduced form (NADH) by accepting and donating electrons. Through this redox cycle, NAD⁺ powers metabolic reactions in glycolysis, the citric acid (Krebs) cycle, and mitochondrial oxidative phosphorylation. Without sufficient NAD⁺, cellular energy production is severely impaired.
            Beyond its metabolic role, NAD⁺ is also consumed by several enzymes crucial for cellular maintenance. Sirtuins (a family of longevity-associated proteins) and poly(ADP-ribose) polymerases (PARPs, which are DNA repair enzymes) both require NAD⁺ as a substrate. Accordingly, NAD⁺ availability is intimately linked to genomic stability, stress resistance, and cell survival. In young organisms, NAD⁺ levels are high, supporting robust sirtuin activity. With aging, however, NAD⁺ concentrations decline substantially—studies estimate that tissues can lose over 50% of their NAD⁺ between youth and old age. This drop is attributed to a combination of increased NAD⁺ consumption (for instance, chronic inflammation elevates the NAD⁺-degrading enzyme CD38, and accumulating DNA damage hyperactivates PARPs) and decreased NAD⁺ synthesis. The outcome is a form of cellular energy deficit: low NAD⁺ impairs mitochondrial function, slows DNA repair, and reduces sirtuin activity. These changes are detrimental to healthy aging.
            Conversely, restoring NAD⁺ levels in animal models have shown promising rejuvenating effects. In aged mice, supplementation with NAD⁺ precursors such as nicotinamide riboside (NR) or nicotinamide mononucleotide (NMN)—forms of vitamin B3—significantly increases NAD⁺ availability and leads to improved cellular energy metabolism and better physiological function. Treated old mice become more physically active and exhibit improvements in various age-related markers (such as insulin sensitivity and reduced DNA damage). Notably, elevating NAD⁺ can extend lifespan in certain organisms and consistently improve health span (the period of life spent in good health) in many rodent studies. These findings have motivated human clinical trials of NAD⁺-boosting interventions, with the hope that mid-life “repletion” of NAD⁺ in humans might similarly slow aspects of the aging process.

Glutathione 

            Glutathione (GSH) is a small peptide—specifically, a tripeptide composed of the amino acids glutamate, cysteine, and glycine—that serves as the cell’s primary intracellular antioxidant. It is

Search for products

Back to Top
Product has been added to your cart